For the financial year ending September 2015 Ashfield has announced Earnings Before Interest & Tax (EBIT) of £4.91m, compared to £3.58m in the previous financial year.
The results are taken from accounts covering the company’s international operations across Europe, the US and Asia.
“We invested in a number of initiatives in the previous financial year to ensure our business remained competitive in the fast-changing environment,” said global managing director Nicola Burns. “It was fantastic to achieve the return on this investment with such a strong set of results.
“Our exhibition offering added considerable revenue across our global operations and the commercial development of ‘spark thinking’ has helped us enhance and diversify our creative service offering. As a result, our US headquarters have just moved into new office space to ensure we have an inspiring and motivating environment for our talented staff to be their best.”
“The market continues to evolve and we are developing and investing in integrated apps, systems and software solutions to help meet the changing needs of our pharmaceutical and life science clients. This includes supporting transfer of value reporting requirements and strategic meetings management implementation.
“The recent collaborative development of the Science Of Meetings approach with our colleagues in the wider Ashfield division has been well received by our clients. In an increasingly regulated environment, it is allowing us to act as a strategic partner to clients and explore multichannel opportunities that offer new types of value for their healthcare professional communication and event strategies.”